ROSE PHARMA A/S: Financial statements 2015
CVR: 27174965
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ROSE PHARMA A/S (CVR 27174965) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -170,730 and a net result of DKK -186,905 compared with DKK 249,739 the year before. Equity in the 2015 report amounted to DKK 1,031,148. The solvency ratio was 73.5%.
- Gross Profit
- DKK -170,730
- Profit/Loss
- DKK -186,905
- Equity
- DKK 1,031,148
- Total Assets
- DKK 1,403,825
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -171 t. | -187 t. | 1 mio. | - |
| 2014 | - | 263 t. | 250 t. | 1.2 mio. | - |
| 2013 | - | -130 t. | -134 t. | 968 t. | - |
| 2012 | - | -335 t. | -335 t. | 1.1 mio. | - |
Official annual report
How creditworthy is ROSE PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
ROSE PHARMA A/S has published its annual report for 2014. Gross profit came to DKK 262,551, and the net result was DKK 249,739.
As of January 7, 2015, Florian Schønharting has left the board of directors of ROSE PHARMA A/S.
About ROSE PHARMA A/S
ROSE PHARMA A/S was a Danish company of the type Aktieselskab based in Roskilde, founded in 2003. The company has been dissolved on 23 April 2020. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GASTROTECH PHARMA A/S and GASTROTECH A/S. The company has 1 employee (2007). In 2016, the company reported a gross profit of DKK -35,218 and a net result of DKK -51,821 compared with DKK -186,905 the year before. Equity in the 2016 report amounted to DKK 979,327.